Extended access to nicotine leads to a CRF1receptor dependent increase in anxiety-like behavior and hyperalgesia in rats: CRF1receptors and nicotine
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Tobacco dependence is associated with the emergence of negative emotional states during withdrawal, including anxiety and nociceptive hypersensitivity. However, the current animal models of nicotine dependence have focused on the mechanisms that mediate the acute reinforcing effects of nicotine and failed to link increased anxiety and pain during abstinence with excessive nicotine self-administration. Here, we tested the hypothesis that the activation of corticotropin-releasing factor-1 (CRF1 ) receptors and emergence of the affective and motivational effects of nicotine abstinence only occur in rats with long access (>21 hours/day, LgA) and not short (1 hour/day, ShA) access to nicotine self-administration. ShA and LgA rats were tested for anxiety-like behavior, nociceptive thresholds, somatic signs of withdrawal and nicotine intake after 3 days of abstinence. The role of CRF1 receptors during abstinence was tested using systemic or intracerebral infusion of MPZP (N,N-bis(2-methoxyethyl)-3-(4-methoxy-2-methylphenyl)-2,5-dimethyl-pyrazolo(1,5α)pyrimidin-7-amine), a CRF1 receptor antagonist, in the central nucleus of the amygdala (CeA). LgA but not ShA rats exhibited abstinence-induced increases in anxiety-like behavior and nociceptive hypersensitivity, which both predicted subsequent excessive nicotine intake and were prevented by systemic administration of MPZP. Intra-CeA MPZP infusion prevented abstinence-induced increases in nicotine intake and nociceptive hypersensitivity. These findings demonstrate that the model of short access to nicotine self-administration has limited validity for tobacco dependence, highlight the translational relevance of the model of extended-intermittent access to nicotine self-administration for tobacco dependence and demonstrate that activation of CRF1 receptors is required for the emergence of abstinence-induced anxiety-like behavior, hyperalgesia and excessive nicotine intake.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Contributions of the Amygdala to Emotion Processing: From Animal Models to Human Behavior
Phelps, E. A., & LeDoux, J. E. (2005) · Neuron · doi:10.1016/j.neuron.2005.09.025 · Cited by 3,203 · cited 1×
“…systemically or directly into the CeA to attenuate the nociceptive hypersensitivity associated with neuropathic and inflammatory pain (Ji & Neugebauer 2007; Hummel et al. 2010) and extends the evidence for a central role for CRF1 receptors in negative emotional states (Phelps & LeDoux 2005).”
Evidence for Addiction-like Behavior in the Rat
Deroche-Gamonet, V., Belin, D., & Piazza, P. V. (2004) · Science · doi:10.1126/science.1099020 · Cited by 1,135
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056 · cited 2×
“and maintain high levels of smoking behavior through negative reinforcement mechanisms (Koob 2008).”
Self-citationGuidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824 · cited 1×
“Nicotine has a very short half-life in rats (T1/2 = 45 minutes; Matta et al. 2007), and the precipitated somatic signs of withdrawal likely reflect the blockade of endogenous cholinergic neurotransmission.”
Symptoms of Tobacco Withdrawal: A Replication and Extension
Hughes, J. R. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250054007 · Cited by 449
Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal
S. Watkins, G. F. K. (2000) · Nicotine & Tobacco Research · doi:10.1080/14622200050011277 · Cited by 424
Reward, addiction, withdrawal to nicotine
De Biasi, M., & Dani, J. A. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113734 · Cited by 366 · cited 1×
“…anxiety-like behavior and nociceptive hypersensitivity Chronic nicotine induces the desensitization and upregulation of nicotine receptors (Quick & Lester 2002), including receptor subtypes known to be involved in withdrawal-induced pain and anxiety (e.g. β4 and α7; De Biasi & Dani 2011).”
Rodent model of nicotine abstinence syndrome
Malin, D. H., Lake, J. R., Newlin-Maultsby, P., Roberts, L. K., Lanier, J. G., Carter, V. A., Cunningham, J. S., & Wilson, O. B. (1992) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(92)90408-8 · Cited by 334 · cited 2×
“Thirty minutes later, they were observed for 10 minutes for somatic signs of withdrawal according to the method developed by Malin et al. (1992) and O’Dell et al. (2007).”
Kenny, P. J., & Markou, A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300905 · Cited by 261
George, O., Ghozland, S., Azar, M. R., Cottone, P., Zorrilla, E. P., Parsons, L. H., O'Dell, L. E., Richardson, H. N., & Koob, G. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707585104 · Cited by 245 · cited 5×
“Increased nicotine intake and motivation for nicotine following 72 hours of abstinence The present results confirm previous studies that reported increased nicotine intake in LgA but not ShA rats after 2–3 days of abstinence (George et al. 2007; O’Dell & Koob 2007; Cohen, Koob & George 2012).”
InfluentialSelf-citationThe Role of α6-Containing Nicotinic Acetylcholine Receptors in Nicotine Reward and Withdrawal
Jackson, K. J., McIntosh, J. M., Brunzell, D. H., Sanjakdar, S. S., & Damaj, M. I. (2009) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155457 · Cited by 135
Dierker, L., & Mermelstein, R. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.11.044 · Cited by 94
Pain is a salient “stressor” that is mediated by corticotropin-releasing factor-1 receptors
Hummel, M., Cummons, T., Lu, P., Mark, L., Harrison, J. E., Kennedy, J. D., & Whiteside, G. T. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.05.001 · Cited by 43
Cited by
Becker, J. A. J., Kieffer, B. L., & Le Merrer, J. (2017) · Addiction Biology · doi:10.1111/adb.12405 · Cited by 77
Kallupi, M., Carrette, L. L. G., Kononoff, J., Solberg Woods, L. C., Palmer, A. A., Schweitzer, P., George, O., & de Guglielmo, G. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1915143117 · Cited by 64
“of tolerance, whereas the negative affective state increases because of neuroadaptive changes that are hypothesized to occur in the central nucleus of the amygdala (CeA) (10-14), among several other key brain regions, such as the bed nucleus of the stria terminalis, ventral tegmental area, habenula, and ventral striat…”
BackgroundSelf-citationBaiamonte, B. A., Valenza, M., Roltsch, E. A., Whitaker, A. M., Baynes, B. B., Sabino, V., & Gilpin, N. W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.025 · Cited by 58
“Antagonism of CRF1Rs attenuates nicotine withdrawal-induced mechanical allodynia, as well as heightened anxiety-like behavior and nicotine self-administration under long-access (23-h/ day) conditions (Cohen et al., 2013; George et al., 2007).”
BackgroundNeuropeptide systems and new treatments for nicotine addiction
Bruijnzeel, A. W. (2017) · Psychopharmacology · doi:10.1007/s00213-016-4513-5 · Cited by 36
“Several neuropeptides have been implicated in nicotine withdrawal-induced anxiety-like behavior including CRF, neuregulin 3 (NRG3), NPY, and dynorphin (Aydin et al. 2011; Cohen et al. 2015; Jackson et al. 2015; Turner et al. 2014).”
InfluentialWang, L., Shen, M., Jiang, C., Ma, L., & Wang, F. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw060 · Cited by 29
Metadata
- Authors
- Cohen, A., Treweek, J., Edwards, S., Leão, R. M., Schulteis, G., Koob, G. F., & George, O.
- Venue
- Addiction Biology
- Publisher
- Wiley
- Published
- 2013-07-22
- Volume
- 20
- Issue
- 1
- Pages
- 56-68
- ISSN
- 1355-6215 (ISSN-L)
- OpenAlex
- W1732913223
- Cited by
- 73
- References
- 13
- FWCI
- 4.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.